鹭燕医药：未来三年股东回报规划（2025-2027年）发布

Core Viewpoint - Luyuan Pharmaceutical (002788) has announced a three-year shareholder return plan for 2025-2027, prioritizing cash dividends and establishing a differentiated cash dividend policy based on various factors [1] Group 1: Shareholder Return Plan - The company will prioritize cash distribution for dividends and will allocate a certain percentage of the distributable profits to shareholders annually, contingent on meeting dividend conditions [1] - The minimum proportion of cash dividends in the profit distribution will be set at 20% [1] - The board will consider industry characteristics, development stage, operational model, profitability, debt repayment capacity, significant capital expenditure plans, and investor returns when proposing the cash dividend policy [1]